The latest update is out from Hays plc ( (GB:HAS) ).

Discover key Q3 2025 insights for Aware, Inc. (AWRE)—33% revenue growth, biometric innovation, and outlook for recurring revenue.

Immunovant remains a high-risk, high-reward play, hinging on the success of its next-gen candidate IMVT-1402. Click to read my latest analysis of IMVT stock.

Ares Management (NYSE: ARES) is preparing to release its quarterly earnings on Monday, 2025-11-03. Here's a brief overview of ...

We may only still be in October, but a St Patrick’s Day vibe – tinged with black – has swept through Chicago this week.

Return on Assets (ROA): Affiliated Managers Group's ROA falls below industry averages, indicating challenges in efficiently ...

Based on the strong quarterly performance, Interface raised its full-year 2025 revenue guidance to $1.375-1.390 billion from its previous outlook of $1.370-1.390 billion. The company also increased ...

The Federal Reserve's 25-basis-point rate cut could lower mortgage rates, presenting opportunities for homebuyers.

PRESSADVANTAGE – StephenTwomey.com has published a new article titled “Alternative Investment Opportunities 2026: Trends & What’s Next”, providing accredited investors with a forward-looking analysis ...

Durin‌g​ market recoveri‍es and extended bull marke‍ts, the S&P 500⁠ High‍ Dividen⁠d Index has typically b​ou​nced back ...

What began as a system designed to make victims whole has become one in which financiers gamble on corporate risk aversion.

Macquarie maintains a neutral stance on ANZ and NAB but rates CBA and WBC as underperform, with Judo Capital being the only bank rated outperform and trading below its target price. The big 4 banks ...